New Frontier Bio, Inc. — Form D
New Frontier Bio, Inc. of BEVERLY, MA, a company, filed a Form D exempt-offering notice with the SEC on 2022-09-26. The offering totals $12.0M, of which $8.9M was reported sold. Industry: Other.
Offering
- Filed: 2022-09-26
- Form: D
- Accession: 0001840005-22-000002
- Industry: Other
- Exemptions: 06b
- Total offering: $12.0M
- Amount sold: $8.9M
- Remaining: $3.1M
- Minimum investment: $40K
- Investors: 11
- Date of first sale: 2022-09-13
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-459846
Issuer
- Name: New Frontier Bio, Inc.
- CIK: 0001840005
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 48 DUNHAM RIDGE, SUITE 5600, BEVERLY, MA, 01915
- Phone: 6178345809
Officers, directors & promoters (17)
| Name | Role | Location |
|---|
| James P Linton | Director | Carlsbad, CA |
| Vincent P Mai | Director | Beverly, MA |
| Serge P Schoen | Director | Beverly, MA |
| Stephen Kennedy Smith | Director | Beverly, MA |
| Kaiyuan P Wang | Director | Beverly, MA |
| Kevin P Kong | Executive Officer | Beverly, MA |
| Stephen Kennedy Smith | Executive Officer | Beverly, MA |
| James P Linton | Promoter | Carlsbad, CA |
| Stephen Kennedy Smith | Promoter | Beverly, MA |
| Stephen Smith | Director | New York, NY |
| Stephen Smith | Executive Officer | New York, NY |
| Stephen Smith | Promoter | New York, NY |
| Kevin Kong | Executive Officer | Beverly, MA |
| Serge Schoen | Director | Beverly, MA |
| Vincent Mai | Director | Beverly, MA |
| Kaiyuan Wang | Director | Beverly, MA |
| James Linton | Director | Beverly, MA |
Other filings by this issuer (1)
More